IRWD - Ironwood Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue298,276273,957149,555
Cost of Revenue19,0971,86812
Gross Profit279,179272,089149,543
Operating Expenses
Research Development148,228139,492108,746
Selling General and Administrative201,813183,112125,247
Non Recurring30937417,638
Total Operating Expenses356,564323,959-
Operating Income or Loss-77,385-51,870-102,088
Income from Continuing Operations
Total Other Income/Expenses Net-3,1829,315-9,485
Earnings Before Interest and Taxes-80,567-42,555-111,573
Interest Expense36,37039,15331,096
Income Before Tax-116,937-81,708-142,669
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-116,937-81,708-142,669
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-116,937-81,708-142,669
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-116,937-81,708-142,669